Insider Trading
Current insider transactions (SEC Form 4) — buys and sells by officers, directors, and major shareholders.
| Ticker | Insider | Title | Date | Transaction | Price ($) | Shares | Value ($) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|
| ROIV | Epperly Melissa B, | Director | 09/10/2026 | Steuer-Abgabe | 40.94 | 2,179 | 89,208 | Form 4 |
| ROIV | Oren Ilan | Director | 09/10/2026 | Steuer-Abgabe | 40.94 | 2,378 | 97,355 | Form 4 |
| ROIV | Fitzgerald Meghan | Director | 09/10/2026 | Steuer-Abgabe | 40.94 | 1,743 | 71,358 | Form 4 |
| ROIV | Momtazee James C | Director | 09/10/2026 | Steuer-Abgabe | 40.94 | 2,905 | 118,931 | Form 4 |
| ROIV | Gold Daniel Allen | Director | 09/10/2026 | Steuer-Abgabe | 40.94 | 5,133 | 210,145 | Form 4 |
| ROIV | Fitzgerald Meghan | Director | 09/08/2026 | Verkauf | 39.90 | 20,000 | 798,000 | Form 4 |
| ROIV | Fitzgerald Meghan | Director | 09/08/2026 | Optionsausübung | 8.80 | 20,000 | 176,000 | Form 4 |
| ROIV | Venker Eric | President & Immunovant CEO | 08/28/2026 | Verkauf | 36.44 | 33,818 | 1,232,328 | Form 4 |
| ROIV | Venker Eric | President & Immunovant CEO | 08/28/2026 | Verkauf | 35.63 | 166,182 | 5,921,065 | Form 4 |
| ROIV | Venker Eric | President & Immunovant CEO | 08/28/2026 | Optionsausübung | 3.85 | 200,000 | 770,000 | Form 4 |
| ROIV | Sukhatme Mayukh | President & CIO | 08/21/2026 | Verkauf | 36.48 | 144,756 | 5,280,699 | Form 4 |
| ROIV | Sukhatme Mayukh | President & CIO | 08/21/2026 | Optionsausübung | 3.85 | 144,756 | 557,311 | Form 4 |
| ROIV | Pulik Richard | CFO | 08/20/2026 | Steuer-Abgabe | 36.84 | 5,749 | 211,793 | Form 4 |
| ROIV | Venker Eric | President & Immunovant CEO | 08/20/2026 | Steuer-Abgabe | 36.84 | 13,909 | 512,408 | Form 4 |
| ROIV | Sukhatme Mayukh | President & CIO | 08/20/2026 | Verkauf | 37.30 | 17,519 | 653,459 | Form 4 |
| ROIV | Sukhatme Mayukh | President & CIO | 08/20/2026 | Optionsausübung | 3.85 | 17,519 | 67,448 | Form 4 |
| ROIV | Sukhatme Mayukh | President & CIO | 08/19/2026 | Verkauf | 37.17 | 172,899 | 6,426,656 | Form 4 |
| ROIV | Sukhatme Mayukh | President & CIO | 08/19/2026 | Optionsausübung | 3.85 | 172,899 | 665,661 | Form 4 |
| ROIV | Sukhatme Mayukh | President & CIO | 08/18/2026 | Verkauf | 37.18 | 31,801 | 1,182,361 | Form 4 |
| ROIV | Sukhatme Mayukh | President & CIO | 08/18/2026 | Optionsausübung | 3.85 | 31,801 | 122,434 | Form 4 |
| ROIV | Sukhatme Mayukh | President & CIO | 08/18/2026 | Verkauf | 36.59 | 105,141 | 3,847,109 | Form 4 |
| ROIV | Sukhatme Mayukh | President & CIO | 08/18/2026 | Optionsausübung | 3.85 | 105,141 | 404,793 | Form 4 |
| ROIV | Sukhatme Mayukh | President & CIO | 08/17/2026 | Verkauf | 36.25 | 284,707 | 10,320,629 | Form 4 |
| ROIV | Sukhatme Mayukh | President & CIO | 08/17/2026 | Optionsausübung | 3.85 | 284,707 | 1,096,122 | Form 4 |
| ROIV | Sukhatme Mayukh | President & CIO | 08/14/2026 | Verkauf | 36.23 | 243,177 | 8,810,303 | Form 4 |
| ROIV | Sukhatme Mayukh | President & CIO | 08/14/2026 | Optionsausübung | 3.85 | 243,177 | 936,231 | Form 4 |
| ROIV | Venker Eric | President & Immunovant CEO | 07/27/2026 | Verkauf | 34.95 | 200,000 | 6,990,000 | Form 4 |
| ROIV | Venker Eric | President & Immunovant CEO | 07/27/2026 | Optionsausübung | 3.85 | 200,000 | 770,000 | Form 4 |
| ROIV | Momtazee James C | Director | 07/17/2026 | Zuteilung | — | 405 | — | Form 4 |
| ROIV | Epperly Melissa B, | Director | 07/17/2026 | Zuteilung | — | 543 | — | Form 4 |
| ROIV | Oren Ilan | Director | 07/17/2026 | Zuteilung | — | 775 | — | Form 4 |
| ROIV | Eric Venker | CEO | 04/20/2026 | Verkauf | 29.59 | 200,000 | 5,918,000 | Form 4 |
A compact market overview — not investment advice. Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q).